| Willow Moryan, CNM | |
|
224 Elm Street, Claremont, NH 03743 | |
| (603) 543-6920 | |
| (603) 542-3543 |
| Full Name | Willow Moryan |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 224 Elm Street, Claremont, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205868809 | NPI | - | NPPES |
| 40Y007826NH01 | Other | NH | BLUE SHIELD |
| 68440 | Other | VT | BLUE SHIELD |
| 373299 | Other | MVP HEALTHCARE | |
| 30343213 | Medicaid | NH | |
| 1010878 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 101.0085851 (Vermont) | Secondary |
| 367A00000X | Advanced Practice Midwife | 046706-23 (New Hampshire) | Primary |
| Entity Name | Planned Parenthood Of Northern New England, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578529350 PECOS PAC ID: 8729069505 Enrollment ID: O20050127000485 |
News Archive
Citing a U.N. report released in May, titled "Trends in Maternal Mortality: 1990 to 2010," which shows "the number of women worldwide dying of pregnancy and childbirth-related complications has almost halved in the last 20 years," Agnes Odhiambo, a researcher for women in Africa at Human Rights Watch, writes in this Inter Press Service opinion piece.
Various types of carbon-based nanomaterials, such as buckyballs and nanotubes, have shown promise as drug delivery tools and imaging agents, but reports of toxicity associated with some of these materials have raised questions about their ultimate utility in clinical oncology.
Heptares Therapeutics Ltd, the drug discovery company focused on G-protein-coupled receptor (GPCR) targets, announced today that it has entered into an option agreement with the Novartis Option Fund under which Heptares will apply its proprietary StaR(TM) technology to generate novel drug leads against a nominated, unspecified GPCR target of interest to Novartis.
The most frequent fungal threat to humans, Candida albicans, is a common cause oral and genital infection. The fungal infections are often worsened by overwhelming inflammatory responses in the body and cause high mortality among risk groups. Umeå University doctoral student Ava Hosseinzadeh has discovered two novel anti-inflammatory agents, an antioxidant and an anti-inflammatory molecule, which could be used to control the hyper-inflammatory responses to the fungal infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Willow Moryan, CNM 784 Hercules Dr Ste 110, Colchester, VT 05446-8049 Ph: (802) 448-9787 | Willow Moryan, CNM 224 Elm Street, Claremont, NH 03743 Ph: (603) 543-6920 |
News Archive
Citing a U.N. report released in May, titled "Trends in Maternal Mortality: 1990 to 2010," which shows "the number of women worldwide dying of pregnancy and childbirth-related complications has almost halved in the last 20 years," Agnes Odhiambo, a researcher for women in Africa at Human Rights Watch, writes in this Inter Press Service opinion piece.
Various types of carbon-based nanomaterials, such as buckyballs and nanotubes, have shown promise as drug delivery tools and imaging agents, but reports of toxicity associated with some of these materials have raised questions about their ultimate utility in clinical oncology.
Heptares Therapeutics Ltd, the drug discovery company focused on G-protein-coupled receptor (GPCR) targets, announced today that it has entered into an option agreement with the Novartis Option Fund under which Heptares will apply its proprietary StaR(TM) technology to generate novel drug leads against a nominated, unspecified GPCR target of interest to Novartis.
The most frequent fungal threat to humans, Candida albicans, is a common cause oral and genital infection. The fungal infections are often worsened by overwhelming inflammatory responses in the body and cause high mortality among risk groups. Umeå University doctoral student Ava Hosseinzadeh has discovered two novel anti-inflammatory agents, an antioxidant and an anti-inflammatory molecule, which could be used to control the hyper-inflammatory responses to the fungal infection.
› Verified 9 days ago
Mrs. Mary E Gardner, ANP,FNP,CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 243 Elm St, Claremont, NH 03743 Phone: 603-542-7771 Fax: 603-542-1153 |